Second-line treatment of ovarian cancer with single-agent gemcitabine (Q34526669)
scientific article
Language:
Current Data About Second-line treatment of ovarian cancer with single-agent gemcitabine
(P31) (Q13442814)
(P248)
(P698) 11840414
(P813) Wednesday, August 2, 2017

(P304) 9-10
(P248)
(P698) 11840414
(P813) Wednesday, August 2, 2017

(P407) (Q1860)

(P433) 1 Suppl 1
(P248)
(P698) 11840414
(P813) Wednesday, August 2, 2017

(P478) 29
(P248)
(P698) 11840414
(P813) Wednesday, August 2, 2017

(P577) Friday, February 1, 2002
(P248)
(P698) 11840414
(P813) Wednesday, August 2, 2017

(P921) (Q172341)
(P887)

(P1433) (Q14330412)
(P248)
(P698) 11840414
(P813) Wednesday, August 2, 2017

(P1476) "Second-line treatment of ovarian cancer with single-agent gemcitabine" (language: en)
(P248)
(P698) 11840414
(P813) Wednesday, August 2, 2017

(P2093) Maurie Markman
(P1545) 1
(P248)
(P698) 11840414
(P813) Wednesday, August 2, 2017

(P13046) (Q7318358)
(P248)

other details